CA
NZ
UK
AU
IND
US
Merck's Keytruda has established itself as the defining immuno-oncology therapy of the past decade through a combination of broad efficacy, a first-mover advantage that allowed it to establish itself as the standard of care across multiple tumour types, and an extraordinary clinical development programme …
Key HighlightsGoldman Sachs set a new price target on Biogen, reflecting revised assumptions about the commercial trajectory of its Alzheimer's diseaseFranchisefollowing the latest clinical and market data.Biogen's Alzheimer's programme, centred on the amyloid-targeting antibody Leqembi developed with Eisai, represents one of the most commercially …
There is a pattern to market openings in the spring of 2026 that traders have come to recognise with a weary familiarity. Oil prices, elevated by the Iran conflict's persistentSupplydisruption, move overnight in response to whatever the most recent geopolitical development happens to be. …
Qatar occupies a position in the global natural gas market that has no precise analogue in any otherCommodity. The country's North Field, the world's largest single natural gas reservoir, has for two decades supplied LNG to buyers across Asia, Europe, and the Americas at …
The markets conversation about artificial intelligence has been dominated by semiconductor stocks, foundation model companies, and the hyperscalers building the data centres that house them. Less attention has been paid to the power infrastructure layer that makes all of it physically possible. Without reliable, …
The development of oral versions of GLP-1 receptor agonist medications, which have demonstrated transformative efficacy in obesity treatment primarily in injectable formats, represents one of the largest commercial opportunities in pharmaceutical history. Injectables have been the dominant format for GLP-1 therapy since the category …
Whirlpool's products, including washing machines, refrigerators, dishwashers, and ovens, occupy a specific position in the consumer spending hierarchy that makes the company's demand data a useful early warning indicator for broader consumer health. Appliance purchases are discretionary in timing even when they are not …
The sharpReversalin shares of TransMedics Group, Inc. (NASDAQ: TMDX) highlights a familiar dynamic unfolding across high-growth healthcare technology companies: investors remain willing to tolerate temporary earnings pressure when long-term structural growth remains intact.
The sharp retreat in shares of Cipher Mining Inc. reflects a familiar tension that frequently emerges in high-growth, high-Volatilitysectors: the divergence between bullish external narratives and cautious internal behaviour.
The sharp decline in shares of IREN Limited on Monday underscored an increasingly uncomfortable reality confronting growth-oriented infrastructure plays: even strong operational narratives can struggle to withstand a deteriorating macro backdrop.
Please wait processing your request...